| P2093 | author name string | Ming-Feng Chen | |
| | Miao-Lin Hu | |
| | Chih-Min Yang | |
| | Cheng-Ming Su | |
| P2860 | cites work | Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice | Q24644317 |
| | Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo | Q24678072 |
| | Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer | Q28331832 |
| | Dose translation from animal to human studies revisited | Q29618049 |
| | Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine | Q33632356 |
| | A new recommended dietary allowance of vitamin C for healthy young women | Q33934001 |
| | Clinical perspectives on platinum resistance | Q33948747 |
| | Vitamin C pharmacokinetics: implications for oral and intravenous use. | Q33977273 |
| | Vitamin C and cancer revisited | Q34595214 |
| | Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity | Q37259459 |
| | High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis | Q37321347 |
| | A simple method of estimating progression of chronic renal failure | Q39413560 |
| | Inhibitory effect of vitamin C in combination with vitamin K3 on tumor growth and metastasis of Lewis lung carcinoma xenografted in C57BL/6 mice | Q39480259 |
| | Fundamental studies with cisplatin | Q39817688 |
| | Oxidants in mitochondria: from physiology to diseases | Q40437348 |
| | Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats | Q43760936 |
| | Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig. | Q44259310 |
| | Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study | Q44976163 |
| | Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice | Q46159319 |
| | Determination of subcutaneous tumor size in athymic (nude) mice | Q46296687 |
| | Preventive effect of aminoguanidine compared to vitamin E and C on cisplatin-induced nephrotoxicity in rats. | Q46442470 |
| | Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocopherol | Q46470958 |
| | Mutogenic action of ascorbic acid | Q50227654 |
| | Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin. | Q50522380 |
| | The Effect of Dietary Supplementation with Vitamins A, C and E on Cell-mediated Immune Function in Elderly Long-stay Patients: A Randomized Controlled Trial | Q52874718 |
| | Ascorbic Acid: Biologic Functions and Relation to Cancer | Q55042014 |
| P433 | issue | 7 | |
| P921 | main subject | vitamin C | Q199678 |
| P304 | page(s) | 1085-1091 | |
| P577 | publication date | 2014-08-26 | |
| P1433 | published in | Nutrition and Cancer | Q7070508 |
| P1476 | title | Vitamin C protects against cisplatin-induced nephrotoxicity and damage without reducing its effectiveness in C57BL/6 mice xenografted with Lewis lung carcinoma | |
| P478 | volume | 66 | |